Oral Lichen Planus: How Mixed Fungal–Bacterial Dysbiosis Shapes Chronic Oral Mucosal Inflammation

April 2026 | By Dr. Kathleen Carson, DDS

Founder, Oral-Vitality

Introduction:Strong opening statement

Oral Lichen Planus (OLP) is a chronic, immune-mediated condition affecting 0.5–2% of adults. While historically viewed through a purely immunological lens, emerging evidence indicates that oral dysbiosis both fungal and bacterial may significantly influence its persistence and clinical behavior.This evolving understanding reframes OLP as a condition shaped not only by host immune responses but also by the microbial ecology of the oral cavity.

OLP as a T-cell–mediated inflammatory disorder

OLP presents as reticular, atrophic, or erosive mucosal lesions affecting the buccal mucosa, gingiva, tongue, and lips.

It is characterized by:

• chronic activation of T lymphocytes

• epithelial barrier disruption

• heightened inflammatory signaling

• alterations in the local mucosal environment

Although the exact trigger remains multifactorial, the interplay between host immunity and the oral microbiome has gained clinical relevance in recent years.

Why this matters systemically

Although localized to the oral cavity, OLP reflects biological pathways common to chronic inflammatory and autoimmune conditions:

• impaired epithelial barrier integrity

• persistent cytokine activation

• microbial immune interactions

• alterations in tissue oxygenation and microecology

Because the oral cavity functions as a gateway to systemic immunity, OLP offers a clinically relevant model for understanding how microbial shifts can amplify or sustain mucosal inflammation more broadly.

What the evidence shows

A. Mixed fungal dysbiosis: Reduced diversity with fungal overgrowth

Studies consistently report:

• ↓ decreased fungal diversity

• ↑ increased abundance of Candida and Aspergillus genera

This shift produces meaningful ecological consequences:

• Candida consumes oxygen at high rates

• Oxygen depletion creates micro-anaerobic niches

• These niches favor colonization by anaerobic bacteria associated with chronic mucosal inflammation

B.Bacterial dysbiosis distinct to OLP

Unlike periodontitis typically associated with reduced bacterial diversity OLP shows:

Higher bacterial diversity compared to healthy controls.

More frequently identified bacterial genera include:

• Treponema

• Bacteroides

• Aggregatibacter

• Veillonella

These organisms thrive in environments characterized by:

• reduced oxygen tension

• chronic inflammatory mediators

• epithelial disruption

C. The synergistic microenvironment: Fungal bacterial interaction

The interaction between fungi and bacteria appears central to OLP biology:

1. Candida overgrowth reduces oxygen availability

2. This creates an anaerobic microenvironment

3. Anaerobic, inflammation-associated bacteria proliferate

4. Persistent microbial immune interaction sustains inflammation

This cycle may help explain why some patients experience prolonged or recurrent inflammatory activity.

D. Considerations regarding malignant potential

Although the overall risk is low, OLP particularly the erosive or atrophic forms has a documented association with malignant transformation.

Current evidence does not establish causation but suggests that dysbiosis may act as:

• an amplifier of chronic inflammation

• a contributor to local oxidative stress

• a source of microbial metabolites that sustain mucosal activation

The microbiome is therefore being studied as a potential cofactor not a primary cause in the biological trajectory of OLP.

How this fits within the Oral-Vitality framework

Oral-Vitality views the oral cavity as:

• Diagnostic window into systemic health

• Regulator of inflammation

• Potential early biomarker of immune dysregulation.

Bottom line

• OLP is not solely an immune-mediated mucosal disorder; the oral microbiome appears to participate in shaping its inflammatory environment.

• Reduced fungal diversity and Candida overgrowth create anaerobic niches that support inflammation-associated bacteria.

• The combined fungal bacterial dysbiosis contributes to persistent immune activation and may help explain clinical variability.

• Understanding these ecological interactions supports a more comprehensive approach to evaluating mucosal health.

• This perspective aligns with modern oral–systemic medicine, emphasizing prevention, early detection, and the role of microbial biomarkers.